IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx(TM) DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma July 9, 2026
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities July 8, 2026
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development July 8, 2026